Holen Sie sich die Stockscreener-App
2.38
8.68%
0.19
Schlusskurs vom Vortag:
$2.19
Offen:
$2.19
24-Stunden-Volumen:
117.23K
Relative Volume:
0.97
Marktkapitalisierung:
$20.74M
Einnahmen:
$2.05M
Nettoeinkommen (Verlust:
$-27.28M
KGV:
-0.4132
EPS:
-5.76
Netto-Cashflow:
$-18.89M
1W Leistung:
+10.70%
1M Leistung:
-22.98%
6M Leistung:
+2.15%
1J Leistung:
+792.72%
1-Tages-Spanne:
$2.19
$2.3845
1-Wochen-Bereich:
$2.0646
$2.3918
52-Wochen-Spanne:
$0.20
$4.98
iBio Inc Stock (IBIO) Company Profile
Firmenname
iBio Inc
Sektor
Branche
Telefon
302-355-0650
Adresse
600 Madison Avenue, Suite 1601, New York, NY
Vergleichen Sie IBIO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| IBIO | 2.37 | 20.74M | 2.05M | -27.28M | -18.89M | -5.76 |
| VRTX | 450.42 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 746.72 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 590.27 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 246.44 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 107.08 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
iBio Inc Stock (IBIO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-11-29 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2021-01-22 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-06-26 | Eingeleitet | Alliance Global Partners | Buy |
iBio Inc Aktie (IBIO) Neueste Nachrichten
iBio Inc. stock falls Wednesday, underperforms market - MarketWatch
iBio Inc. stock rises Tuesday, outperforms market - MarketWatch
iBio Inc. stock rises Friday, outperforms market - MarketWatch
Ikarian Capital, LLC Adjusts Stake in iBio Inc - GuruFocus.com
ADAR1 Capital Management's Strategic Acquisition in iBio Inc - GuruFocus.com
iBio Inc. stock falls Thursday, underperforms market - MarketWatch
iBio Inc Reports Fiscal Q1 GAAP EPS of -$0.52, Missing Estimates; No Revenue Reported, Aligning with Expectations - GuruFocus.com
iBio Inc. stock falls Tuesday, underperforms market - MarketWatch
iBio Reports Fiscal First Quarter 2025 Financial Results - GlobeNewswire
iBio (NYSE:IBIO) Trading Down 0.6% – Here’s What Happened - Defense World
iBio Inc. stock remains steady Monday, underperforms market - MarketWatch
iBio Inc. stock rises Monday, outperforms market - MarketWatch
iBio Unveils AI-Driven Antibody Discovery Strategy - TipRanks
Plant-Based Vaccines Market Is Booming Worldwide 2024-2031 | - openPR
iBio Inc. stock remains steady Thursday, underperforms market - MarketWatch
iBio Inc. stock rises Wednesday, outperforms market - MarketWatch
iBio Inc. stock falls Monday, underperforms market - MarketWatch
Biopharmaceuticals Contract Manufacturing Industry Research 2024-2030: Biopharma Giants Increasingly Outsource to Streamline Drug Developments - GlobeNewswire Inc.
Lead molecule identified under Ibio and Astralbio’s myostatin program for obesity - BioWorld Online
Items Tagged with 'Astralbio Inc.' - BioWorld Online
iBio and AstralBio Provide Update on Myostatin Program for Obesity - GlobeNewswire
IBio, Inc. and AstralBio Provide Update on Myostatin Program for Obesity - Marketscreener.com
IBIO’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle
What is going on with iBio Inc? Sentiment Analysis - US Post News
iBio Inc. stock falls Friday, underperforms market - MarketWatch
iBio Inc. stock rises Thursday, outperforms market - MarketWatch
iBio (NYSE:IBIO) Trading 1.6% Higher - Defense World
Inogen: Upside Seems Limited After Big Move Up (NASDAQ:INGN) - Seeking Alpha
Biafra: Why We Ended Nnamdi Kanu’s Trial – Lawyer Ejimakor - Tori.ng
Analytical Overview: ImmunityBio Inc (IBRX)’s Ratios Tell a Financial Story - The Dwinnex
Immunome (NASDAQ:IMNM) Shares Down 5.6% After Insider Selling - MarketBeat
IOVA’s price-to-free cash flow ratio: How it affects investment decisions - US Post News
Finanzdaten der iBio Inc-Aktie (IBIO)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.80%
0.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):